NASDAQ · Financial Statements
Structure Therapeutics Inc. (GPCR) Financial Statements
$53.36
NASDAQ: GPCR
Market Cap $3.07B
Overview Financials Dividend Structure Therapeutics Inc. most recently reported annual revenue of $0, net profit of $-141.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-38.0M $-53.0M $-103.0M $-158.0M $-288.0M Net Profit $-40.0M $-51.0M $-90.0M $-123.0M $-141.0M EPS $-1.20 $-1.44 $-2.43 $-2.34 $-2.40 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $111.0M $98.0M $482.0M $903.0M $1.6B Total Liabilities $176.0M $213.0M $29.0M $38.0M $68.0M Cash $105.0M $26.0M $130.0M $170.0M $800.0M Borrowings $1.0M $0 $5.0M $4.0M $6.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-32.0M $-46.0M $-79.0M $-117.0M $-222.0M Investing Cash Flow $17.0M $-62.0M $-271.0M $-360.0M $86.0M Financing Cash Flow $0 $-2.0M $-21.0M $1.0M $-5.0M Net Cash Flow $89.0M $-79.0M $104.0M $40.0M $630.0M Free Cash Flow $-33.0M $-46.0M $-82.0M $-118.0M $-226.0M
Valuation & Return Ratios
Metric Value PEG Ratio 1.00 EV / EBITDA -16.46 FCF Yield -5.18% Quick Ratio 26.16 Interest Coverage 0.00 Return 1Y 176.86% Return 3Y 47.77% Return 5Y —
Screens featuring this stock